Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ginkgo Bioworks Holdings Q3 EPS $(1.45) Misses $(1.24) Estimate, Sales $38.837M Miss $38.850M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:14pm
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.45) per share which missed the analyst consensus estimate of $(1.24) by 16.94 percent. This is a 34.26 percent decrease over losses of $(1.08) per share from the same period last year. The company reported quarterly sales of $38.837 million which missed the analyst consensus estimate of $38.850 million by 0.03 percent. This is a 56.39 percent decrease over sales of $89.046 million the same period last year.

Posted In: DNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist